Dishman Carbogen Amics (NSE:DCAL) Scaled Net Operating Assets: N/A (As of Mar. 2026)


NSE:DCAL Dishman Carbogen Amics Ltd NSE:DCAL
71 GF Score
Price ₹175.37
GF Value ₹237.00
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Dishman Carbogen Amics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Dishman Carbogen Amics's operating assets for the quarter that ended in Mar. 2026 was ₹108,925 Mil. Dishman Carbogen Amics's operating liabilities for the quarter that ended in Mar. 2026 was ₹21,704 Mil. Dishman Carbogen Amics's Total Assets for the quarter that ended in Dec. 2025 was ₹0 Mil. Therefore, Dishman Carbogen Amics's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was N/A.


Dishman Carbogen Amics Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Dishman Carbogen Amics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dishman Carbogen Amics Scaled Net Operating Assets Chart

Dishman Carbogen Amics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 0.89 0.79 0.81 0.87

Dishman Carbogen Amics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:DCAL vs VRTX, REGN, ALNY: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, Dishman Carbogen Amics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dishman Carbogen Amics Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dishman Carbogen Amics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Dishman Carbogen Amics's Scaled Net Operating Assets falls into.


NSE:DCAL
71GF Score
Dishman Carbogen Amics Ltd NSE:DCAL
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dishman Carbogen Amics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Dishman Carbogen Amics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2026 )
=(Operating Assets (A: Mar. 2026 )-Operating Liabilities (A: Mar. 2026 ))/Total Assets (A: Mar. 2025 )
=(108925.1-21703.5)/99991.5
=0.87

where

Operating Assets(A: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=119233.1 - 10308
=108925.1

Operating Liabilities(A: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=52464.1 - 17581.5 - 13179.1
=21703.5

Dishman Carbogen Amics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Dec. 2025 )
=(108925.1-21703.5)/0
=N/A

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=119233.1 - 10308
=108925.1

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=52464.1 - 17581.5 - 13179.1
=21703.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Dishman Carbogen Amics (NSE:DCAL) Overvalued in 2026?

Based on GuruFocus' analysis, Dishman Carbogen Amics stock appears to be undervalued. The current stock price of ₹175.37 is trading 26% below its estimated GF Value™ of ₹237.00. GuruFocus considers Dishman Carbogen Amics to be Modestly Undervalued.

Key valuation signals for NSE:DCAL:

  • Scaled Net Operating Assets: N/A
  • GF Value™: ₹237.00 vs. price of ₹175.37 (26% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the NSE:DCAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dishman Carbogen Amics Business Description

Other Exchanges 540701:India
Address Iscon-Bopal Road, Dishman Corporate House, Ambli, Ahmedabad, GJ, IND, 380 058
Dishman Carbogen Amics Ltd is a biotechnology company that provides contract research and manufacturing services for pharmaceutical companies. It manufactures bulk drugs, specialty chemicals, and outsourced goods. Additionally, the company produces vitamins, such as vitamin D2 and vitamin D3, reagents, antiseptics and disinfectants, transfer catalysts, personal-care ingredients, pharma intermediates, and ammonium and phosphonium high-purity solid Quats. The business generates the vast majority of its revenue in India.
71GF Score

Get the complete analysis for NSE:DCAL

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹175.37
Price
₹237.00
GF Value